Rose S Bernal-larioza, MD - Medicare Physical Medicine And Rehabilitation in Chicopee, MA

Rose S Bernal-larioza, MD is a medicare enrolled "Physical Medicine & Rehabilitation" physician in Chicopee, Massachusetts. She graduated from medical school in 2002 and has 22 years of diverse experience with area of expertise as Physical Medicine And Rehabilitation. She is a member of the group practice Holyoke Medical Center Inc and her current practice location is 444 Montgomery St, Chicopee, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (413) 594-3111.

Rose S Bernal-larioza is licensed to practice in Massachusetts (license number 234525) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1053529453.

Contact Information

Rose S Bernal-larioza, MD
444 Montgomery St,
Chicopee, MA 01020-1969
(413) 594-3111
(413) 598-7040



Physician's Profile

Full NameRose S Bernal-larioza
GenderFemale
SpecialityPhysical Medicine And Rehabilitation
Experience22 Years
Location444 Montgomery St, Chicopee, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Rose S Bernal-larioza graduated from medical school in 2002
  NPI Data:
  • NPI Number: 1053529453
  • Provider Enumeration Date: 05/18/2007
  • Last Update Date: 01/26/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 3072680560
  • Enrollment ID: I20080925000271

Medical Identifiers

Medical identifiers for Rose S Bernal-larioza such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053529453NPI-NPPES
110080962/AMedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208100000XPhysical Medicine & Rehabilitation 234525 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Holyoke Medical CenterHolyoke, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Holyoke Medical Center Inc2163419383122

News Archive

In Texas, abstinence-only programs may contribute to teen pregnancies

To understand why teen pregnancy rates are so high in Texas, meet Jessica Chester. When Chester was in high school in Garland, Texas, she decided to attend the University of Texas-Dallas. She wanted to become a doctor.

Sorting out end-of-life, long-term care issues as America ages

As America ages, end-of-life and long-term care issues increase. One doctor is helping families cope with end-of-life care while a looming shortage of caregivers worries some.

Roper Industries prices 2.3M shares of its common stock at $53.15 per share

Roper Industries, Inc. announced today that it has priced a registered public offering of 2,300,000 shares of its common stock at $53.15 per share. The net proceeds of the offering are expected to be approximately $121 million after underwriting discounts and commissions and estimated offering expenses.

Researchers reveal potential biological roots behind individuality

Scientists have studied the system that controls age-appropriate behavior and discovered a certain element of variation that may contribute to a species' survival from an evolutionary point of view.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Rose S Bernal-larioza allows following entities to bill medicare on her behalf.
Entity NameHolyoke Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750395737
PECOS PAC ID: 2163419383
Enrollment ID: O20040429000312

News Archive

In Texas, abstinence-only programs may contribute to teen pregnancies

To understand why teen pregnancy rates are so high in Texas, meet Jessica Chester. When Chester was in high school in Garland, Texas, she decided to attend the University of Texas-Dallas. She wanted to become a doctor.

Sorting out end-of-life, long-term care issues as America ages

As America ages, end-of-life and long-term care issues increase. One doctor is helping families cope with end-of-life care while a looming shortage of caregivers worries some.

Roper Industries prices 2.3M shares of its common stock at $53.15 per share

Roper Industries, Inc. announced today that it has priced a registered public offering of 2,300,000 shares of its common stock at $53.15 per share. The net proceeds of the offering are expected to be approximately $121 million after underwriting discounts and commissions and estimated offering expenses.

Researchers reveal potential biological roots behind individuality

Scientists have studied the system that controls age-appropriate behavior and discovered a certain element of variation that may contribute to a species' survival from an evolutionary point of view.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Read more Medical News

› Verified 5 days ago

Entity NameRiverbend Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841651197
PECOS PAC ID: 5698064343
Enrollment ID: O20160614001710

News Archive

In Texas, abstinence-only programs may contribute to teen pregnancies

To understand why teen pregnancy rates are so high in Texas, meet Jessica Chester. When Chester was in high school in Garland, Texas, she decided to attend the University of Texas-Dallas. She wanted to become a doctor.

Sorting out end-of-life, long-term care issues as America ages

As America ages, end-of-life and long-term care issues increase. One doctor is helping families cope with end-of-life care while a looming shortage of caregivers worries some.

Roper Industries prices 2.3M shares of its common stock at $53.15 per share

Roper Industries, Inc. announced today that it has priced a registered public offering of 2,300,000 shares of its common stock at $53.15 per share. The net proceeds of the offering are expected to be approximately $121 million after underwriting discounts and commissions and estimated offering expenses.

Researchers reveal potential biological roots behind individuality

Scientists have studied the system that controls age-appropriate behavior and discovered a certain element of variation that may contribute to a species' survival from an evolutionary point of view.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rose S Bernal-larioza is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Rose S Bernal-larioza, MD
444 Montgomery St,
Chicopee, MA 01020-1969

Ph: (413) 594-3111
Rose S Bernal-larioza, MD
444 Montgomery St,
Chicopee, MA 01020-1969

Ph: (413) 594-3111

News Archive

In Texas, abstinence-only programs may contribute to teen pregnancies

To understand why teen pregnancy rates are so high in Texas, meet Jessica Chester. When Chester was in high school in Garland, Texas, she decided to attend the University of Texas-Dallas. She wanted to become a doctor.

Sorting out end-of-life, long-term care issues as America ages

As America ages, end-of-life and long-term care issues increase. One doctor is helping families cope with end-of-life care while a looming shortage of caregivers worries some.

Roper Industries prices 2.3M shares of its common stock at $53.15 per share

Roper Industries, Inc. announced today that it has priced a registered public offering of 2,300,000 shares of its common stock at $53.15 per share. The net proceeds of the offering are expected to be approximately $121 million after underwriting discounts and commissions and estimated offering expenses.

Researchers reveal potential biological roots behind individuality

Scientists have studied the system that controls age-appropriate behavior and discovered a certain element of variation that may contribute to a species' survival from an evolutionary point of view.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Read more News

› Verified 5 days ago


Physical Medicine & Rehabilitation Doctors in Chicopee, MA


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.